Inflammatory Bowel Disease (IBD) Clinical Trial
Official title:
Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
Inflammatory bowel disease (IBD) is a chronic, debilitating, relapsing inflammatory disorder affecting the gastrointestinal tract which does not have a medical cure. IBD consists of 2 different forms: Crohn's Disease (CD) and Ulcerative Colitis (UC). In the last 2 decades, Gut Microbial Transplantation (GMT), also known as fecal transplantation, has been used as a treatment option for Clostridium difficile colitis and UC. The literature supports strong evidence for the plausibility of using GMT for patients with IBD associated colitis, especially for patients with UC. This research will be conducted in the Helen DeVos Children's Hospital (HDVCH) Pediatric gastrointestinal outpatient clinic. A pilot study of ten patients will be conducted to evaluate if GMT improves clinical symptoms in patients with IBD. Patients with IBD colitis (UC and CD with colonic involvement only) will be approached for GMT as a treatment option for their disease. Each subject will undergo 5 sessions (1 session/day, and not necessarily on consecutive days) of GMT within a period of 10 days. Post treatment evaluation will be done at their regularly scheduled clinic follow up. Healthy donors >18 years of age will be chosen by the family, inclusive of immediate family members and friends. Donors will be required to complete a screening questionnaire, provide medical history, and undergo blood and stool tests.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05428345 -
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
|
||
| Completed |
NCT02265588 -
Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD).
|
N/A | |
| Completed |
NCT01022749 -
Efficacy Safety Study of Flu Vaccine in Immunodepression Patients
|
Phase 3 | |
| Completed |
NCT02461758 -
Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients
|
Phase 4 | |
| Completed |
NCT01095042 -
Cognition and Emotion in the SII and IBD
|
N/A | |
| Completed |
NCT00542776 -
Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine
|
N/A | |
| Completed |
NCT02778464 -
Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease
|
||
| Completed |
NCT02256605 -
Vitamin D3 Supplementation in Pediatric IBD: Weely vs Daily Dosing Regimens
|
N/A | |
| Recruiting |
NCT05078879 -
Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency
|
Phase 1 | |
| Completed |
NCT05596422 -
A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)
|
||
| Completed |
NCT02355834 -
Faecal Incontinence iNtervention Study
|
N/A | |
| Not yet recruiting |
NCT01852097 -
An Online Intervention to Address Barriers to IBD Medication Adherence
|
N/A | |
| Terminated |
NCT00325078 -
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
|
Phase 1/Phase 2 | |
| Terminated |
NCT03886753 -
Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
|
||
| Recruiting |
NCT04345393 -
Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes
|
N/A | |
| Completed |
NCT01819766 -
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
|
N/A | |
| Completed |
NCT00820365 -
SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease
|
Phase 2 | |
| Completed |
NCT02156557 -
Study of KCC Peptide Application in the Colon
|
Phase 1 | |
| Completed |
NCT01364896 -
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
|
||
| Terminated |
NCT00152620 -
Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease
|
N/A |